pressure on actelion rises after asahi case decision
swiss biotech group actelion ltd  is now facing a tougher battle at its annual general meeting next week after a jury decided asahi kasei pharma corporation  should be awarded up to $547 million.
http://feeds.reuters.com/~r/reuters/businessnews/~3/o6ze5s6ncyu/us-actelion-idustre74031q20110501
34401
01 May 2011 23:52:39
reuters
business